ASMANEX is a Respiratory (inhalation) Inhalant in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Mometasone Furoate.
| Product ID | 0085-1341_22ce7e61-648f-4680-b024-f35096bf5d82 |
| NDC | 0085-1341 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ASMANEX |
| Generic Name | Mometasone Furoate |
| Dosage Form | Inhalant |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2005-03-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021067 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | MOMETASONE FUROATE |
| Active Ingredient Strength | 220 ug/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2005-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-03-30 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Marketing End Date | 2014-10-07 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Marketing End Date | 2015-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Marketing Category | NDA |
| Application Number | NDA021067 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-30 |
| Ingredient | Strength |
|---|---|
| MOMETASONE FUROATE | 220 ug/1 |
| SPL SET ID: | 1ec2b62b-6bf5-4d70-8824-9d90e2d87a68 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0085-1341 | ASMANEX | Mometasone Furoate |
| 0085-1461 | ASMANEX | Mometasone Furoate |
| 0085-2222 | ASMANEX HFA | MOMETASONE FUROATE |
| 0085-4333 | ASMANEX HFA | MOMETASONE FUROATE |
| 0085-4334 | ASMANEX HFA | MOMETASONE FUROATE |
| 0085-0370 | ELOCON | mometasone furoate |
| 0085-0854 | ELOCON | Mometasone Furoate |
| 0085-3149 | ELOCON | Mometasone Furoate |
| 0168-0270 | Mometasone Furoate | mometasone furoate |
| 0168-0271 | Mometasone Furoate | mometasone furoate |
| 0168-0272 | Mometasone Furoate | mometasone furoate |
| 0713-0634 | Mometasone Furoate | Mometasone Furoate |
| 0113-1720 | Nasonex | mometasone furoate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ASMANEX 78489101 3127884 Dead/Cancelled |
MERCK SHARP & DOHME CORP. 2004-09-24 |
![]() ASMANEX 76029251 not registered Dead/Abandoned |
SCHERING CORPORATION 2000-04-18 |
![]() ASMANEX 74462173 2136067 Live/Registered |
MERCK SHARP & DOHME CORP. 1993-11-22 |